Use of a broad-host-range gyrA plasmid for genetic characterization of fluoroquinolone-resistant gram-negative bacteria.
about
DNA gyrase, topoisomerase IV, and the 4-quinolonesA mutation in Escherichia coli DNA gyrase conferring quinolone resistance results in sensitivity to drugs targeting eukaryotic topoisomerase IITopoisomerase IV is a target of quinolones in Escherichia coliEmergence of fluoroquinolone-resistant Escherichia coli at a cancer center.Impact of gyrA and parC mutations on quinolone resistance, doubling time, and supercoiling degree of Escherichia coli.Contribution of the C-8 substituent of DU-6859a, a new potent fluoroquinolone, to its activity against DNA gyrase mutants of Pseudomonas aeruginosa.Role of mutations in DNA gyrase genes in ciprofloxacin resistance of Pseudomonas aeruginosa susceptible or resistant to imipenem.Genetic evidence for a role of parC mutations in development of high-level fluoroquinolone resistance in Escherichia coli.Topoisomerase IV, not gyrase, decatenates products of site-specific recombination in Escherichia coli.Mutations in the gyrA gene of a highly fluoroquinolone-resistant clinical isolate of Escherichia coli.Characterization of fluoroquinolone-resistant mutants of escherichia coli selected in vitro.Detection of a Novel gyrB Mutation Associated With Fluoroquinolone-Nonsusceptible Salmonella enterica serovar Typhimurium Isolated From a Bloodstream Infection in Ghana.Alteration of Membrane Permeability of Bacteria and Yeast by High Frequency Alternating Current (HFAC)Relationships among ciprofloxacin, gatifloxacin, levofloxacin, and norfloxacin MICs for fluoroquinolone-resistant Escherichia coli clinical isolatesBacteremia due to quinolone-resistant Escherichia coli in a teaching hospital in South Korea.Effects of rifaximin on bacterial virulence mechanisms at supra- and sub-inhibitory concentrations.Resistance mechanism of Acinetobacter spp. strains resistant to DW-116, a new quinolone.Clinical significance and spread of fluoroquinolone resistant uropathogens in hospitalised urological patients.[Fluoroquinolone carboxylic acids: is research on the development of resistance becoming invalidated?]
P2860
Q24643546-463B5033-802C-478B-BCCF-D6BBBF6F3533Q30448695-78632A87-8637-48D0-BC0F-9BC5686CFD6EQ33724600-9DC0A27F-FF55-4BB7-9FEF-24C169787C4CQ33752287-5A967E34-79CE-4CF4-9A15-0134D0E571B8Q33976675-8EC222D2-2D10-4A6C-88B7-30C1685A9F85Q35115957-381C5B84-1999-43A5-97C7-DA9E6C9342BFQ35119495-F4028645-CF33-4C6F-8BD0-F08EF26FE943Q35123629-10D2374A-8328-45C6-9C3C-DD978451715CQ35192431-A15AF14E-B22E-4B40-B79D-21E24130047DQ35811107-612A6F25-BFF3-4867-86C4-A87C548DE6A6Q35821472-9B78A87F-624C-4BA1-A42A-79F7ED10946BQ38865973-E1C39250-77C4-4A0B-9E3E-D1058CEC007DQ41377280-9E90C961-45DA-4334-AD98-E9530A928499Q41975822-512D6693-5A79-455F-9EA3-6409B1C9465FQ43593616-73278857-2FF7-403F-AC03-FA8E4A4715D1Q46604531-75A806E8-0338-469A-9185-13801E415B4AQ54110217-B2368034-A09B-4398-B0B6-F878FC9EBE49Q54221203-D29EEF10-21D2-48D8-9B81-1A2650E9CDD5Q54227945-D2A71F2C-8BB1-4383-A31D-469516E49D80
P2860
Use of a broad-host-range gyrA plasmid for genetic characterization of fluoroquinolone-resistant gram-negative bacteria.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Use of a broad-host-range gyrA ...... istant gram-negative bacteria.
@ast
Use of a broad-host-range gyrA ...... istant gram-negative bacteria.
@en
type
label
Use of a broad-host-range gyrA ...... istant gram-negative bacteria.
@ast
Use of a broad-host-range gyrA ...... istant gram-negative bacteria.
@en
prefLabel
Use of a broad-host-range gyrA ...... istant gram-negative bacteria.
@ast
Use of a broad-host-range gyrA ...... istant gram-negative bacteria.
@en
P2860
P356
P1476
Use of a broad-host-range gyrA ...... istant gram-negative bacteria.
@en
P2093
P2860
P304
P356
10.1128/AAC.35.10.2031
P407
P577
1991-10-01T00:00:00Z